OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on the OTCQB® Venture Marketplace:
Barfresh Food Group Inc. (OTCQB: BRFH) – Barfresh Food Group is a leader in the creation of, manufacturing and distributing ready-to-blend beverages. The current portfolio of products is made up of smoothies, shakes and frappes. All of the products are portion controlled and ready to blend beverage ingredient packs or “beverage packs.” Domestic and international patents and patents pending are owned by Barfresh, as well as related trademarks for all of the products. Product development and new flavor creation is a critical element of the business. The leadership team has been developing flavor profiles for each beverage category that will appeal to tastes in the United States. The company has been in discussions with a number of companies including both large and small quick service restaurant (“QSR”) chains and full service restaurant chains (“FSR”). Additionally, there are also discussions with national food service companies that serve alternative venues such as stadiums, arenas and universities with national footprints in the United States. Preliminary agreements with three potential customers have been reached and testing in these venues will begin in the near future. There are also other ongoing negotiations taking place with several of national foodservice companies.
In addition to the large fast food, fast casual and full service restaurant chains, the company will sell to food distributors that supply products to the food services marketplace. Effective July 2, 2014, the company entered into an agreement with Sysco Merchandising and Supply Chain Services, Inc. for resale by the Sysco Corporation ("Sysco") to the foodservice industry of the company's ready-to-blend smoothies, shakes and frappes. All Barfresh products will be included in Sysco's national core selection of beverage items, making Barfresh its exclusive single-serve, pre-portioned beverage provider.
Bio-AMD, Inc. (OTCQB: BIAD) – Bio-AMD is a developer of medical diagnostic technologies for application in near- patient devices. In December 2014, it entered into a Master Agreement with Sysmex, a global leader in haematology diagnostics, for the development of a coagulation meter (COAG). In addition, it has developed a semi-quantitative Digital Strip Reader (DSR) and intends to develop a fully quantitative Magnetic Immunoassay Detection System (MIDS).
Capstone Therapeutics Corp. (OTCQB: CAPS) – Capstone Therapeutics is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with underserved medical conditions.
Chuma Holdings, Inc. (OTCQB: CHUM) – Chuma and its wholly-owned subsidiaries provide turnkey financing and support solutions to the rapidly evolving and growing legal cannabis industry. It provides "seed to sale" key business services including:
> Funding and Financing Solutions
> Compliance Consulting Solutions
> Retail, Collective and Dispensary Solutions
> Banking and Payment Processing Solutions
> Multichannel Supply Chain Solutions
> Branding, Marketing and Sales Solutions
> Research and Development Solutions
> Consumer Product Solutions
> Commercial Production and Equipment Build Out Solutions
Chuma's experienced team has over 35 years of successful experience in the lawfully organized cannabis industry in California, and it is currently generating revenue from existing financing and service solutions. It is planning on expanding throughout California and bringing its array of services to each new state that legalizes the use of cannabis.
CTD Holdings, Inc. (OTCQB: CTDH) – CTD Holdings is a family of biotechnology growth companies based on cyclodextrin chemistry. Its individual divisions distribute and manufacture the trademarked Trappsol(R) and Aquaplex(R) cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies involved in research, pharmaceutical, medical device, cosmetics and nutrition markets. Sphingo Biotechnology, Inc. is developing Trappsol(R) Cyclo(TM), an orphan drug designated product, for the treatment of Niemann Pick Type C, a rare and fatal genetic disease in young children. NanoSonic Products, Inc. operates the world's only cGMP pulse drying facility for the production of Ultra-Pure(TM) cyclodextrin derivatives and pharmaceutical grade Aquaplex(R) cyclodextrin complexes. CTD, Inc. supplies cyclodextrins to biotechnology and life science researchers around the globe from the world's largest catalog of cyclodextrins. The companies offer a wide variety of cyclodextrin related manufacturing services to worldwide customers, including custom formulation, manufacturing, and commercial scale supply of pharmaceutical grade cyclodextrin complexes.
Ener-Core, Inc. (OTCQB: ENCR) – Ener-Core designs, develops, and manufactures products based on proprietary technologies that aim to expand the power-generation range of gaseous fuels. It considers "power" to consist of industrial grade heat used to generate electricity, create steam through a boiler, or used in heat exchanger applications. It also strives to use its technologies to provide a power generating solution with a significantly reduced air emissions profile. It refers to these technologies collectively as "Power Oxidization" or "Power Oxidizer" (previously called "Gradual Oxidation" and "Gradual Oxidizer," respectively in its prior SEC filings). The company’s products aim to expand power generation to low quality gas fuel sources that have previously been uneconomical or outright non-feasible fuels for generating energy. At the same time, its products reduce gaseous emissions from industrial processes that contribute to air pollution and climate change.
Intellect Neurosciences, Inc. (OTCQB: ILNS) – Intellect Neurosciences is a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of neurodegenerative conditions, especially proteinopathies. These conditions include Alzheimer’s disease, Parkinson’s and Huntington’s disease, Frontotemporal Dementia and age related macular degeneration. The company’s internal drug discovery programs are focused on the therapeutic applications of monoclonal antibodies and antibody-drug conjugates. Intellect has granted licenses to global pharmaceutical companies covering several of the patents in its intellectual property portfolio, which will entitle the company to significant milestone payments and sales based royalties upon successful development and commercialization of the licensed drug candidates.
Monarch America, Inc. (OTCQB: BTFL) – Monarch America is a fully integrated management and consulting company delivering trusted high-value products, services, and turnkey solutions to the legal and regulated marijuana industry. While not directly engaged in the sale of marijuana, Monarch America is equipped to oversee and manage all facets of retail operations, from property management, and technology and equipment leasing, to inventory control, staffing, and day-to-day operational management. The company's wholly-owned subsidiary, The Big Tomato, Inc., is a leading supplier of hydroponics & indoor gardening supplies for Denver, Colorado and the surrounding communities since May of 2001. Monarch America also develops and markets various high-quality branded hydroponics and commercial growing products for national distribution.
SigmaBroadband Co. (OTCQB: SGRB) – SigmaBroadband is in the business of delivering innovative communications, information and entertainment over intelligent wireless, wireline, cable, fiber, broadband and global Internet Protocol (“IP”) networks that meets its customers' growing demand for speed, mobility, security and control.
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected
financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to inform investors of opportunities and risks: the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and the OTC Pink® Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, saskia@otcmarkets.com